These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7427063)

  • 1. Factors determining outcome of reversed saphenous vein femoropopliteal bypass grafts.
    Sonnenfeld T; Cronestrand R
    Br J Surg; 1980 Sep; 67(9):642-8. PubMed ID: 7427063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history of above- and below-knee femoropopliteal grafts.
    Blackshear WM; Thiele BL; Strandness DE
    Am J Surg; 1980 Aug; 140(2):234-41. PubMed ID: 7406131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Composite polytetrafluroethylene/vein bypass grafts: conventional distal vein segment or vein cuff?
    Karacagil S; Holmberg A; Narbani A; Eriksson I; Bergqvist D
    Eur J Vasc Endovasc Surg; 1996 Oct; 12(3):337-41. PubMed ID: 8896477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-operative graft blood flow related to failure of femoro-popliteal bypass grafts.
    Sonnenfeld T; Cronestrand R
    Scand J Thorac Cardiovasc Surg; 1980; 14(1):101-4. PubMed ID: 6445589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Femoropopliteal bypass: saphenous vein and expanded polytetrafluoroethylene grafts.
    Wooster DL; Provan JL; Sojka SG; Madras PN
    Can J Surg; 1982 Nov; 25(6):666-9. PubMed ID: 7139424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The advantages of the great saphenous vein as a femoropopliteal graft. A report on its clinical use.
    Sonnenfeld T; Cronestrand R
    Scand J Thorac Cardiovasc Surg; 1980; 14(3):285-90. PubMed ID: 7221503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Femoropoliteal bypass graft patency: An analysis of 156 cases.
    Miller VM
    Ann Surg; 1974 Jul; 180(1):35-8. PubMed ID: 4835957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Femoropopliteal prosthetic bypass with glutaraldehyde stabilized human umbilical vein (HUV).
    Neufang A; Espinola-Klein C; Dorweiler B; Messow CM; Schmiedt W; Vahl CF
    J Vasc Surg; 2007 Aug; 46(2):280-8. PubMed ID: 17600663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The significance of vein wall thickness and diameter in relation to the patency of femoropopliteal saphenous vein bypass grafts.
    Buxton B; Lambert RP; Pitt TT
    Surgery; 1980 Apr; 87(4):425-31. PubMed ID: 7368087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of the immediate outcome of femoropopliteal saphenous vein bypass by angiographic runoff score.
    Albäck A; Biancari F; Saarinen O; Lepäntalo M
    Eur J Vasc Endovasc Surg; 1998 Mar; 15(3):220-4. PubMed ID: 9587334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The great saphenous vein used in situ after vein valve extirpation. Long term results.
    Rostad H; Hall KV; Dundas P
    J Cardiovasc Surg (Torino); 1979; 20(6):545-52. PubMed ID: 511920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ femoropopliteal and distal vein bypass for limb salvage--experience of 50 cases.
    Denton MJ; Hill D; Fairgrieve J
    Br J Surg; 1983 Jun; 70(6):358-61. PubMed ID: 6860911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superficial femoral-popliteal veins and reversed saphenous veins as primary femoropopliteal bypass grafts: a randomized comparative study.
    Schulman ML; Badhey MR; Yatco R
    J Vasc Surg; 1987 Jul; 6(1):1-10. PubMed ID: 3599276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Above-knee polytetrafluoroethylene femoropopliteal bypass graft: Is it a reasonable alternative to the below-knee reversed autogenous vein graft?
    O'Donnell TF; Farber SP; Richmand DM; Deterling RA; Callow AD
    Surgery; 1983 Jul; 94(1):26-31. PubMed ID: 6857508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distal femoropopliteal bypass using a composite graft of PTFE and non-reversed saphenous vein.
    Holdsworth PJ; Riddell PS; Leveson SH
    Ann R Coll Surg Engl; 1989 Jan; 71(1):4-6. PubMed ID: 2923418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. David M. Hume memorial lecture. In situ vein bypass in the treatment of femoropopliteal atherosclerotic disease: a ten year study.
    Hall KV; Rostad H
    Am J Surg; 1978 Aug; 136(2):158-61. PubMed ID: 686254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New technique for construction of coposite Dacron vein grafts for femoro-distal popliteal bypass in the severely ischemic leg.
    Lord JW; Sadranagani B; Bajwa G; Rossi G
    Ann Surg; 1975 May; 181(5):670-5. PubMed ID: 124161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and anatomic considerations for surgery in femoropopliteal disease and the results of surgery.
    Taylor LM; Porter JM
    Circulation; 1991 Feb; 83(2 Suppl):I63-9. PubMed ID: 1991402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fate of the limb after failed femoropopliteal reconstruction.
    Wooster DL; Provan JL
    Can J Surg; 1982 Jul; 25(4):393-7. PubMed ID: 7093838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sparks mandril, velour Dacron and autogenous saphenous vein grafts in femoropopliteal bypass.
    Christenson JT; Eklöf B
    Br J Surg; 1979 Jul; 66(7):514-7. PubMed ID: 157181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.